Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 22606 AL 22620

Alzheimer disease: Amyloid peptide controversies and challenges of anti-Aβ immunotherapy

Almohmadi NH, Al-Kuraishy HM, Albuhadily AK, Al-Gareeb AI, Abdelaziz AM, Alexiou A, Papadakis M, El-Saber Batiha G.

J Pharmacol Exp Ther. 2025 Aug;392(8):103639. doi: 10.1016/j.jpet.2025.103639. Epub 2025 Jun 20.

Deciphering Molecular and Signaling Pathways of Extracellular Vesicles-Based Therapeutics for Alzheimer's Disease

Dhapola R, Kumari S, Sharma P, Paidlewar M, Medhi B, Vellingiri B, HariKrishnaReddy D.

Mol Neurobiol. 2025 Dec;62(12):15430-15449. doi: 10.1007/s12035-025-05216-6. Epub 2025 Jul 18.

Eriocitrin and its derivatives against Alzheimer's disease: Cumulative accounts of in vitro and in vivo studies

Kritika, Sanjay, Lee HJ.

Biomed Pharmacother. 2025 Sep;190:118362. doi: 10.1016/j.biopha.2025.118362. Epub 2025 Jul 21.

A novel therapeutic prospect: a dual-acting tirzepatide for Alzheimer's disease

Alshehri GH, Al-Kuraishy HM, Al-Gareeb AI, Fawzy MN, Waheed HJ, Papadakis M, Alexiou A, El-Saber Batiha G.

Eur J Pharmacol. 2025 Sep 15;1003:177979. doi: 10.1016/j.ejphar.2025.177979. Epub 2025 Jul 22.

Is dolichol pathway dysfunction a significant factor in Alzheimer's disease?

Schloss JV.

Inflammopharmacology. 2025 Aug;33(8):4651-4658. doi: 10.1007/s10787-025-01868-x. Epub 2025 Jul 25.

Understanding the Insulin-Degrading Enzyme: A New Look at Alzheimer's Disease and Aβ Plaque Management

Cerasuolo M, Auriemma MC, Di Meo I, Lenti C, Papa M, Paolisso G, Rizzo MR.

Int J Mol Sci. 2025 Jul 12;26(14):6693. doi: 10.3390/ijms26146693.

The role of peripheral innate immune cells in Alzheimer's disease progression

Cao Y, Tang K, Ma P, Zhang R, Yang Y, Li T, Zhang Y, Peng X.

Front Immunol. 2025 Jul 16;16:1616939. doi: 10.3389/fimmu.2025.1616939. eCollection 2025.

Alzheimer's disease: unraveling role of xanthone derivatives and nanocarriers

Suhaili INA, Yow HY, Mah SH, Zaman Huri H, Tan SLJ.

Naunyn Schmiedebergs Arch Pharmacol. 2026 Jan;399(1):1-17. doi: 10.1007/s00210-025-04446-8. Epub 2025 Aug 1.

Exploring the Interconnections of Genetic, Lifestyle, and Epigenetic Influences on Brain Aging: A Comprehensive Review

Mehrabadi S, Barati S.

Curr Alzheimer Res. 2025;22(7):488-501. doi: 10.2174/0115672050393583250718145103.

Adaptive immunity in the neuroinflammation of Alzheimer's disease

Liu H, Chen Y, Zhang J, Chen X.

Chin Med J (Engl). 2025 Sep 5;138(17):2116-2129. doi: 10.1097/CM9.0000000000003695. Epub 2025 Aug 5.

Phytocompounds as modulators of HSF1 in neurodegenerative disease: Special emphasis on Alzheimer's disease

Nelson VK, Begum MY, Dera AA, Ali SP, Suryadevara PR.

Eur J Pharmacol. 2025 Oct 15;1005:178034. doi: 10.1016/j.ejphar.2025.178034. Epub 2025 Aug 5.

Hippocampal neural stem cells in Alzheimer's disease: bridging neurogenesis, extracellular vesicles, and multimodal therapeutic paradigms

Li R, Xiong W, Sun C.

Int J Neurosci. 2026 Mar;136(3):380-400. doi: 10.1080/00207454.2025.2540989. Epub 2025 Aug 8.

Management of sleep disturbance related to Alzheimer disease and dementia: An updated review of ClinicalTrials.gov

Aldurdunji MM.

Medicine (Baltimore). 2025 Aug 8;104(32):e43725. doi: 10.1097/MD.0000000000043725.

From APOE to cellular changes: Unraveling the multidimensional mechanisms of blood-brain barrier damage in Alzheimer's disease

Jiang F, Wang N, Meng Q.

J Alzheimers Dis. 2025 Sep;107(2):421-438. doi: 10.1177/13872877251360321. Epub 2025 Sep 1.

Clusterin Regulates the Mechanisms of Neuroinflammation and Neuronal Circuit Impairment in Alzheimer's Disease

Yu Y, Wang C, Wang B, Wang X, Zhao Q, Yan Y, Liu X.

Int J Mol Sci. 2025 Jul 28;26(15):7271. doi: 10.3390/ijms26157271.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias